BioAtlantis
PrivateLast Round
Grant
Sep 1, 2023
Total Funding Raised
$1.38M
Company Overview
BioAtlantis operates in Healthcare & Life Sciences and is based in Tralee. Its latest recorded funding round was a Grant round in September 2023.
BioAtlantis is a biotechnology company that develops and manufactures natural biostimulants and bio-actives from seaweed for use in the crop, animal, and human health sectors.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Sustainable Materials, Clean Manufacturing
Business Model
B2B
Customer Profile
Hardware Sales, Government Contracts, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioAtlantis Comparables
Compare BioAtlantis with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Brandon Bioscience | 86% | |
| Beijing Leili Marine Bioindustry Inc. | 83% | |
| Kelp Products International | 83% |
For institutional investors. Book with your work email.
BioAtlantis Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Sep 1, 2023 | ||||
| Grant | Jan 1, 2023 | ||||
| Seed | Jun 7, 2010 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioAtlantis Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Kernel Capital | Seed |
| European Union | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 17, 2026
Grew 22% QoQ, from 36 to 44 employees.
- Nov 13, 2025
Monthly visitors increased 45% MoM, reaching 2.5K.
For institutional investors. Book with your work email.
BioAtlantis Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioAtlantis's valuation, stock price, and market status.
Is BioAtlantis a public or private company?
BioAtlantis is a private company.
What is the current stock price of BioAtlantis?
BioAtlantis is a private company, so its shares have no public market price. Caplight tracks BioAtlantis's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioAtlantis worth (valuation)?
Valuation information for BioAtlantis is not publicly available.
Can I buy BioAtlantis stock?
BioAtlantis shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioAtlantis's last funding round?
BioAtlantis's most recent funding round was Grant on September 1, 2023.
Who are the main investors in BioAtlantis?
Key investors in BioAtlantis include Kernel Capital.
Will BioAtlantis IPO soon?
No public IPO plans have been announced for BioAtlantis.
How can I track BioAtlantis secondary market activity?
Caplight tracks bids, offers, and trades in BioAtlantis's shares on secondary markets.